Iridium-Based Compound for Photodynamic Therapy
February 11, 2020 | Terry Sharrer
Photodynamic therapy has had some, but limited, success is destroying cancers, such as bladder tumors. This approach may now accelerate with a sensitizing agent of iridium. “The iridium compound works to destroy the nicotinamide adenine dinucleotide (NADH) co-enzyme by catalytically destroying it or changing it into its oxidized form. NADH is an important part of cellular energy generating processes, so attacking it effectively starves the cancer cells.” MORE
Image Credit: University of Warwick